Where Will Silverback Therapeutics Inc (SBTX) Stock Go Next After It Has Risen 8.97% in a Week?

Friday, October 21, 2022 03:45 PM | InvestorsObserver Analysts

Mentioned in this article

Where Will Silverback Therapeutics Inc (SBTX) Stock Go Next After It Has Risen 8.97% in a Week?

Overall market sentiment has been high on Silverback Therapeutics Inc (SBTX) stock lately. SBTX receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Silverback Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SBTX!

See Full SBTX Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With SBTX Stock Today?

Silverback Therapeutics Inc (SBTX) stock has fallen -3.22% while the S&P 500 has risen 2.45% as of 3:40 PM on Friday, Oct 21. SBTX is down -$0.19 from the previous closing price of $5.90 on volume of 163,906 shares. Over the past year the S&P 500 is down -17.21% while SBTX is down -37.87%. SBTX lost -$2.57 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Silverback Therapeutics Inc click here.

More About Silverback Therapeutics Inc

Silverback Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on leveraging its ImmunoTAC technology platform to develop tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. Click Here to get the full Stock Report for Silverback Therapeutics Inc stock.